Hysterectomy: What Needs to be Removed?

Mary Jane Minkin

Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Medical Treatment of Locally Advanced and Metastatic Cervical Cancer…

OncoAlert

D. Lorusso

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

Endometrial Cancer: Risk Factors, Prognostic Challenges, and Staging…

Hope Cottrill

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

Phase 3 ROSELLA Trial Press Release: Primary Endpoint Met As Relacor…

Bradley J. Monk

Comprehensive Review of PARP Inhibitors in Ovarian Cancer: Role of O…

Alexander Olawaiye

SOCCER-P Trial: Secondary Cytoreductive Surgery in Relapsed Ovarian …

Hyun-Woong Cho

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2024 Updates in Clinical Practice for Ovarian Cancer

OncoAlert

I. Ray-Coquard

The Changing Field of Endometrial Cancer Treatment

GRACE

M. Raza Mirza

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza